Search Results - "Koning, Harry J de"

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study by Ten Haaf, Kevin, Jeon, Jihyoun, Tammemägi, Martin C, Han, Summer S, Kong, Chung Yin, Plevritis, Sylvia K, Feuer, Eric J, de Koning, Harry J, Steyerberg, Ewout W, Meza, Rafael

“…Selection of candidates for lung cancer screening based on individual risk has been proposed as an alternative to criteria based on age and cumulative smoking…”
Get full text

Prostate-Cancer Mortality at 11 Years of Follow-up by Schröder, Fritz H, Hugosson, Jonas, Roobol, Monique J, Tammela, Teuvo L.J, Ciatto, Stefano, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Lilja, Hans, Zappa, Marco, Denis, Louis J, Recker, Franz, Páez, Alvaro, Määttänen, Liisa, Bangma, Chris H, Aus, Gunnar, Carlsson, Sigrid, Villers, Arnauld, Rebillard, Xavier, van der Kwast, Theodorus, Kujala, Paula M, Blijenberg, Bert G, Stenman, Ulf-Hakan, Huber, Andreas, Taari, Kimmo, Hakama, Matti, Moss, Sue M, de Koning, Harry J, Auvinen, Anssi

“…The European Randomized Study of Screening for Prostate Cancer continues to show a 21% reduction in prostate-cancer mortality in the screening group, after 11…”
Get full text

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers by Horeweg, Nanda, Dr, Scholten, Ernst Th, MD, de Jong, Pim A, PhD, van der Aalst, Carlijn M, PhD, Weenink, Carla, MD, Lammers, Jan-Willem J, Prof, Nackaerts, Kristiaan, PhD, Vliegenthart, Rozemarijn, PhD, ten Haaf, Kevin, MSc, Yousaf-Khan, Uraujh A, MD, Heuvelmans, Marjolein A, Thunnissen, Erik, PhD, Oudkerk, Matthijs, Prof, Mali, Willem, Prof, de Koning, Harry J, Prof

“…Summary Background Low-dose CT screening is recommended for individuals at high risk of developing lung cancer. However, CT screening does not detect all lung…”
Get full text

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada by Ten Haaf, Kevin, Tammemägi, Martin C, Bondy, Susan J, van der Aalst, Carlijn M, Gu, Sumei, McGregor, S Elizabeth, Nicholas, Garth, de Koning, Harry J, Paszat, Lawrence F

“…The National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual…”
Get full text

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study by Getaneh, Abraham M., Heijnsdijk, Eveline A. M., de Koning, Harry J.

“…The benefit of prostate cancer screening is counterbalanced by the risk of overdiagnosis and overtreatment. The use of a multi-parametric magnetic resonance…”
Get full text

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up by Schröder, Fritz H, Prof, Hugosson, Jonas, Prof, Roobol, Monique J, PhD, Tammela, Teuvo L J, Prof, Zappa, Marco, MD, Nelen, Vera, MD, Kwiatkowski, Maciej, MD, Lujan, Marcos, MD, Määttänen, Liisa, PhD, Lilja, Hans, Prof, Denis, Louis J, Prof, Recker, Franz, Prof, Paez, Alvaro, MD, Bangma, Chris H, Prof, Carlsson, Sigrid, MD, Puliti, Donella, MSc, Villers, Arnauld, MD, Rebillard, Xavier, MD, Hakama, Matti, Prof, Stenman, Ulf-Hakan, Prof, Kujala, Paula, MD, Taari, Kimmo, MD, Aus, Gunnar, MD, Huber, Andreas, Prof, van der Kwast, Theo H, Prof, van Schaik, Ron H N, Prof, de Koning, Harry J, Prof, Moss, Sue M, Prof, Auvinen, Anssi, Prof

“…Summary Background The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9…”
Get full text

The cost-effectiveness of different visual acuity screening strategies in three European countries: A microsimulation study by Heijnsdijk, Eveline A.M., Verkleij, Mirjam L., Carlton, Jill, Horwood, Anna M., Fronius, Maria, Kik, Jan, Sloot, Frea, Vladutiu, Cristina, Simonsz, Huibert J., de Koning, Harry J.

“…Childhood vision screening programmes in Europe differ by age, frequency and location at which the child is screened, and by the professional who performs the…”
Get full text

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials by Ten Haaf, Kevin, van Rosmalen, Joost, de Koning, Harry J

“…Implementing optimal lung cancer screening programs requires knowledge of the natural history and detectability of lung cancer. This information can be derived…”
Get full text

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening by Horeweg, Nanda, Dr, van Rosmalen, Joost, PhD, Heuvelmans, Marjolein A, van der Aalst, Carlijn M, PhD, Vliegenthart, Rozemarijn, PhD, Scholten, Ernst Th, MD, ten Haaf, Kevin, MSc, Nackaerts, Kristiaan, PhD, Lammers, Jan-Willem J, Prof, Weenink, Carla, MD, Groen, Harry J, Prof, van Ooijen, Peter, PhD, de Jong, Pim A, PhD, de Bock, Geertruida H, PhD, Mali, Willem, Prof, de Koning, Harry J, Prof, Oudkerk, Matthijs, Prof

“…Summary Background The main challenge in CT screening for lung cancer is the high prevalence of pulmonary nodules and the relatively low incidence of lung…”
Get full text

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial by Walter, Joan E, BSc, Heuvelmans, Marjolein A, PhD, de Jong, Pim A, PhD, Vliegenthart, Rozemarijn, Prof, van Ooijen, Peter M A, PhD, Peters, Robin B, MD, ten Haaf, Kevin, MSc, Yousaf-Khan, Uraujh, MD, van der Aalst, Carlijn M, PhD, de Bock, Geertruida H, Prof, Mali, Willem, Prof, Groen, Harry J M, Prof, de Koning, Harry J, Prof, Oudkerk, Matthijs, Prof

“…Summary Background US guidelines now recommend lung cancer screening with low-dose CT for high-risk individuals. Reports of new nodules after baseline…”
Get full text

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial by HOREWEG, Nanda, VAN DER AALST, Carlijn M, LAMMERS, Jan-Willem J, NACKAERTS, Kristiaan, VAN ROSMALEN, Joost, OUDKERK, Matthijs, DE KONING, Harry J, VLIEGENTHART, Rozemarijn, YINGRU ZHAO, XUEQIAN XIE, SCHOLTEN, Ernst Th, MALI, Willem, THUNNISSEN, Erik, WEENINK, Carla, GROEN, Harry J. M

“…Several medical associations recommended lung cancer screening by low-dose computed tomography scanning for high-risk groups. Counselling of the candidates on…”
Get full text

Screening and Prostate-Cancer Mortality in a Randomized European Study by Schröder, Fritz H, Hugosson, Jonas, Roobol, Monique J, Tammela, Teuvo L.J, Ciatto, Stefano, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Lilja, Hans, Zappa, Marco, Denis, Louis J, Recker, Franz, Berenguer, Antonio, Määttänen, Liisa, Bangma, Chris H, Aus, Gunnar, Villers, Arnauld, Rebillard, Xavier, van der Kwast, Theodorus, Blijenberg, Bert G, Moss, Sue M, de Koning, Harry J, Auvinen, Anssi

“…In this trial, investigators tested the effect of prostate-specific–antigen testing on the death rate from prostate cancer in more than 162,000 men between the…”
Get full text

Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial by HOREWEG, Nanda, DER AALST, Carlijn M. Van, MALI, Willem, OUDKERK, Matthijs, DE KONING, Harry J, THUNNISSEN, Erik, NACKAERTS, Kristiaan, WEENINK, Carla, GROEN, Harry J. M, LAMMERS, Jan-Willem J, AERTS, Joachim G, SCHOLTEN, Ernst T, ROSMALEN, Joost Van

“…The NELSON (Nederlands Leuvens Longkanker Screenings Onderzoek) trial is, with 15,822 participants, the largest European lung cancer computer tomography…”
Get full text

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe by Gini, Andrea, Buskermolen, Maaike, Senore, Carlo, Anttila, Ahti, Novak Mlakar, Dominika, Veerus, Piret, Csanádi, Marcell, Jansen, Erik E. L., Zielonke, Nadine, Heinävaara, Sirpa, Széles, György, Segnan, Nereo, de Koning, Harry J., Lansdorp-Vogelaar, Iris

“…Background. Validated microsimulation models have been shown to be useful tools in providing support for colorectal cancer (CRC) screening decisions. Aiming to…”
Get full text

Quality-of-Life Effects of Prostate-Specific Antigen Screening by Heijnsdijk, Eveline A.M, Wever, Elisabeth M, Auvinen, Anssi, Hugosson, Jonas, Ciatto, Stefano, Nelen, Vera, Kwiatkowski, Maciej, Villers, Arnauld, Páez, Alvaro, Moss, Sue M, Zappa, Marco, Tammela, Teuvo L.J, Mäkinen, Tuukka, Carlsson, Sigrid, Korfage, Ida J, Essink-Bot, Marie-Louise, Otto, Suzie J, Draisma, Gerrit, Bangma, Chris H, Roobol, Monique J, Schröder, Fritz H, de Koning, Harry J

“…Quality-of-Life Effects of PSA Screening PSA screening of men between the ages of 55 and 69 years resulted in a reduction in deaths from prostate cancer…”
Get full text

The Role of Conventional Bronchoscopy in the Workup of Suspicious CT Scan Screen-Detected Pulmonary Nodules by van 't Westeinde, Susan C., MD, Horeweg, Nanda, MD, Vernhout, René M., MD, Groen, Harry J.M., MD, PhD, Lammers, Jan-Willem J., MD, PhD, Weenink, Carla, MD, Nackaerts, Kristiaan, MD, PhD, Oudkerk, Matthijs, MD, PhD, Mali, Willem, MD, PhD, Thunnissen, Frederik B., MD, PhD, de Koning, Harry J., MD, PhD, van Klaveren, Rob J., MD, PhD

“…Background Up to 50% of the participants in CT scan lung cancer screening trials have at least one pulmonary nodule. To date, the role of conventional…”
Get full text

Lung cancer screening: latest developments and unanswered questions by van der Aalst, Carlijn M, Dr, ten Haaf, Kevin, MSc, de Koning, Harry J, Prof

“…Summary The US National Lung Screening Trial showed that individuals randomly assigned to screening with low-dose CT scans had 20% lower lung cancer mortality…”
Get full text

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer by Buzzoni, Carlotta, Auvinen, Anssi, Roobol, Monique J, Carlsson, Sigrid, Moss, Sue M, Puliti, Donella, de Koning, Harry J, Bangma, Chris H, Denis, Louis J, Kwiatkowski, Maciej, Lujan, Marcos, Nelen, Vera, Paez, Alvaro, Randazzo, Marco, Rebillard, Xavier, Tammela, Teuvo L.J, Villers, Arnauld, Hugosson, Jonas, Schröder, Fritz H, Zappa, Marco

“…Abstract Background The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a…”
Get full text

Lung cancer screening and smoking cessation efforts by Moldovanu, Dana, de Koning, Harry J., van der Aalst, Carlijn M.

“…Randomized-controlled trials have confirmed substantial reductions in lung cancer mortality with low-dose computed tomography (LDCT) screening. Evidence on how…”
Get full text

Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening by Davidović, Maša, Zielonke, Nadine, Lansdorp-Vogelaar, Iris, Segnan, Nereo, de Koning, Harry J., Heijnsdijk, Eveline AM

“…To quantify the impact of mammography-based screening on the quality of life, disability-adjusted life years (DALYs) averted or quality-adjusted life years…”
Get full text